In a study, γ-δT cells in combination with galectin-1 antibody treatment, significantly suppressed the growth of tumor xenografts in severe combined immunodeficiency (SCID) mice (p < 0.05), although γδ TILs alone showed the ability to inhibit tumor growth in vivo. The gene discussed is LGALS1; the disease is neoplasm.